Evidence map›Paper›PMID 15743820›Full record

ArticleMolecular and cellular biology2005

Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.

Souad Rahmouni, Torkel Vang, Andres Alonso, Scott Williams, Marianne van Stipdonk, Chiara Soncini, Michel Moutschen, Stephen P Schoenberger, Tomas Mustelin

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Souad RahmouniProgram of Inflammation, Infectious and Inflammatory Disease Center, and Program of Signal Transduction, Cancer Center, The Burnham Institute, 10901 North Torrey Pines Rd., La Jolla, CA 92037, USA.
Torkel Vang
Andres Alonso
Scott Williams
Marianne van Stipdonk
Chiara Soncini
Michel Moutschen
Stephen P Schoenberger
Tomas Mustelin

Funding

ROLE, REGULATION AND SUBSTRATES OF SYK-FAMILY PTKSR01AI035603 · NIAID · SIDNEY KIMMEL CANCER CENTER · PI RICKERT, ROBERT · 1994 to 2007
$2.8M
TRAIL-mediated regulation of T help for CTLR01CA081261 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SCHOENBERGER, STEPHEN PHILIP · 2000 to 2009
$2.7M
HEMATOPOIETIC TYROSINE PHOSPHATASE (HEPTP) IN T CELLSR01AI048032 · NIAID · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI MUSTELIN, TOMAS M · 2000 to 2004
$2.2M
Negative regulation of TCR-associated PTKsR01AI053585 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RICKERT, ROBERT C · 2003 to 2007
$2.1M
PTP-MEG2: Regulation, Substrates, BiologyR01AI055741 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RICKERT, ROBERT C · 2003 to 2007
$1.4M
Regulation of the tumor suppressor PTENR01CA096949 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MUSTELIN, TOMAS M · 2003 to 2006
$1.4M
NCI NIH HHS CA81261NCI NIH HHS CA96949NCI NIH HHS R01 CA081261NCI NIH HHS R01 CA096949NIAID NIH HHS AI35603NIAID NIH HHS AI48032NIAID NIH HHS AI53585NIAID NIH HHS AI55741NIAID NIH HHS R01 AI035603NIAID NIH HHS R01 AI048032NIAID NIH HHS R01 AI053585NIAID NIH HHS R01 AI055741
6 · The paper itself

Abstract

The Csk tyrosine kinase negatively regulates the Src family kinases Lck and Fyn in T cells. Engagement of the T-cell antigen receptor results in a removal of Csk from the lipid raft-associated transmembrane protein PAG/Cbp. Instead, Csk becomes associated with an approximately 72-kDa tyrosine-phosphorylated protein, which we identify here as G3BP, a phosphoprotein reported to bind the SH3 domain of Ras GTPase-activating protein. G3BP reduced the ability of Csk to phosphorylate Lck at Y505 by decreasing the amount of Csk in lipid rafts. As a consequence, G3BP augmented T-cell activation as measured by interleukin-2 gene activation. Conversely, elimination of endogenous G3BP by RNA interference increased Lck Y505 phosphorylation and reduced TCR signaling. In antigen-specific T cells, endogenous G3BP moved into a intracellular location adjacent to the immune synapse, but deeper inside the cell, upon antigen recognition. Csk colocalization with G3BP occurred in this "parasynaptic" location. We conclude that G3BP is a new player in T-cell-antigen receptor signaling and acts to reduce the amount of Csk in the immune synapse.

Indexed as

Adaptor Proteins, Signal TransducingCarrier ProteinsCD3 ComplexCSK Tyrosine-Protein KinaseDNA HelicasesHumansJurkat CellsLigandsLymphocyte ActivationLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane MicrodomainsMembrane ProteinsPhosphoproteinsPhosphorylationPhosphotransferasesPoly-ADP-Ribose Binding ProteinsAdaptor Proteins, Signal TransducingCarrier ProteinsCD3 ComplexCSK protein, humanCSK Tyrosine-Protein KinaseDNA HelicasesG3BP1 protein, humanLigandsLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane ProteinsPAG1 protein, humanPhosphoproteinsPhosphotransferasesPoly-ADP-Ribose Binding ProteinsProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptors, Antigen, T-CellRNA HelicasesRNA Recognition Motif ProteinsRNA, Small Interferingsrc-Family KinasesTyrosine

Identifiers

PMID15743820
PMCPMC1061611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.